Esperion Therapeutics | ESPR - Le Revenu D'Intérêts





Le Revenu D'Intérêts Changement Date
AbbVie USD 59M 13M 2025-12
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
Amarin USD 3.37M 3.37M 2024-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
CSL USD 18M 1000K 2024-12
Cytokinetics USD 11.02M 448K 2026-03
Daiichi Sankyo JPY 9.96B 230M 2024-03
Eli Lilly USD 65M 25M 2025-09
Esperion Therapeutics USD -0.15 0.18 2024-09
Geron USD 4.04M 219K 2025-12
Heron Therapeutics USD 433K 277K 2021-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Merck USD 69M 27M 2025-12
Moderna USD 70M 3M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 115M 51M 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 33M 81M 2025-12
Sarepta Therapeutics USD 8.74M 359K 2025-12
United Therapeutics USD 43.2M 3.2M 2025-12